Kyntra Bio (KYNB) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Kyntra Bio (KYNB) over the last 12 years, with Q3 2025 value amounting to $200.6 million.
- Kyntra Bio's Profit After Tax rose 51546.43% to $200.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $161.5 million, marking a year-over-year increase of 16746.87%. This contributed to the annual value of -$153.1 million for FY2024, which is 5259.68% up from last year.
- According to the latest figures from Q3 2025, Kyntra Bio's Profit After Tax is $200.6 million, which was up 51546.43% from -$13.7 million recorded in Q2 2025.
- In the past 5 years, Kyntra Bio's Profit After Tax registered a high of $200.6 million during Q3 2025, and its lowest value of -$134.1 million during Q4 2021.
- For the 5-year period, Kyntra Bio's Profit After Tax averaged around -$46.8 million, with its median value being -$63.6 million (2023).
- Per our database at Business Quant, Kyntra Bio's Profit After Tax tumbled by 28404.35% in 2022 and then skyrocketed by 51546.43% in 2025.
- Over the past 5 years, Kyntra Bio's Profit After Tax (Quarter) stood at -$134.1 million in 2021, then soared by 50.64% to -$66.2 million in 2022, then tumbled by 43.51% to -$95.0 million in 2023, then skyrocketed by 90.88% to -$8.7 million in 2024, then skyrocketed by 2415.48% to $200.6 million in 2025.
- Its Profit After Tax was $200.6 million in Q3 2025, compared to -$13.7 million in Q2 2025 and -$16.8 million in Q1 2025.